Bavarian Nordic A/S (BVNRY)
| Previous close | 13.86 |
| Open | 13.00 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 13.86 - 13.86 |
| 52-week range | 9.10 - 17.48 |
| Volume | 61 |
| Avg. volume | 208 |
| Market cap | 2.644B |
| Beta (5Y monthly) | 1.47 |
| PE ratio (TTM) | 8.16 |
| EPS (TTM) | 1.70 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 27 Mar 2020 |
| 1y target est | N/A |
- Globe Newswire
Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox
COPENHAGEN, Denmark, June 11, 2021 – Bavarian Nordic A/S (OMX: BAVA) announced today that the Company was recently engaged by Public Health England (PHE) and the Medicines and Health Products Regulatory Agency (MHRA) to supply its IMVANEX® smallpox vaccine in response to new cases of monkeypox in the UK. Two related cases were confirmed and admitted to a hospital in Liverpool. One was most likely infected in Africa, where the family arrived from a few days before onset of disease, and a sibling
- Globe Newswire
Bavarian Nordic A/S - Articles of Association
Updated Articles of Association for Bavarian Nordic A/S. Attachment Bavarian Nordic - Articles of Association
- Globe Newswire
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, June 10, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following transactions of the company’s shares/related securities by persons holding managerial responsibilities and/or persons/companies closely associated with such. 1.Details of the person discharging managerial responsibilities/person closely associated a)NameHenrik Birk2.Reason for the notificationa)Position/statusExecutive Vice President and Chief Operating Officer of B
